title: Heparin-releasable TFPI is not depleted after repeated injections of tinzaparin at therapeutic dose for up to 30 days.
authors.forename: I
authors.initials: I
authors.lastname: Gouin-Thibault
authors.forename: E
authors.initials: E
authors.lastname: Pautas
authors.forename: F
authors.initials: F
authors.lastname: Depasse
authors.forename: J P
authors.initials: JP
authors.lastname: Andreux
authors.forename: V
authors.initials: V
authors.lastname: Siguret
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006493:Heparin / Q000494:pharmacology; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D008074:Lipoproteins / Q000097:blood / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D013927:Thrombosis / Q000188:drug therapy; D000078222:Tinzaparin
chemical_list: D006495:Heparin, Low-Molecular-Weight; D008074:Lipoproteins; C051928:lipoprotein-associated coagulation inhibitor; D000078222:Tinzaparin; D006493:Heparin